CTLA4 and neoplasm: Hettich et al. developed a [64Cu]Cu-NOTA-PD-1 mice mAb which showed specific uptake in lymph nodes and spleen and was able to visualize PD-1+ T cells tumor infiltration in a murine model treated with radiotherapy and CTLA-4/PD-L1 inhibitors [26].